Editorial
doi: 10.1016/j.ijantimicag.2006.06.002.
Epub 2006 Aug 9.
Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin
- PMID: 16904296
- DOI: 10.1016/j.ijantimicag.2006.06.002
Item in Clipboard
Editorial
Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin
Int J Antimicrob Agents.
2006 Sep.
Abstract
At this symposium, the bacterial aetiologies of community-acquired pneumonia and acute exacerbations of chronic bronchitis were evaluated. By reviewing the clinical criteria for the identification of at-risk patients and the recommendations for antimicrobial drug selection in treatment guidelines, the role of levofloxacin in clinical practice was explored. In addition, consideration was also given to the economic impact of using levofloxacin in at-risk patients.